{"disease":{"id":"developmental-and-epileptic-encephalopathy","name":"developmental and epileptic encephalopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06092346","title":"A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":999,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT06380192","title":"Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT06908226","title":"A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":324,"lead_sponsor_name":"Longboard Pharmaceuticals","has_results":false},{"nct_id":"NCT06719141","title":"A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"Longboard Pharmaceuticals","has_results":false},{"nct_id":"NCT05364021","title":"Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Longboard Pharmaceuticals","has_results":false},{"nct_id":"NCT04937062","title":"Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05626634","title":"Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Longboard Pharmaceuticals","has_results":false},{"nct_id":"NCT06412653","title":"Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Children's University Hospital Cologne, Germany","has_results":false},{"nct_id":"NCT06983158","title":"A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":12,"lead_sponsor_name":"Capsida Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT04873869","title":"Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}